President & CEO

Group Vice President, Head Inflammation and AutoImmunity Group

Incyte announces additional FDA approval of Opzelura

US FDA approves Incyte's eczema cream for pediatric patients

Incyte Gets FDA Approval for Dermatitis Cream for Young Children

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

BIS Sales Marketing Sr Mgr

Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines. The Sr. Manager, BIS, Business Intelligence – Sales & Marketing will deliver dashboard and reporting solutions to support sales and marketing initiatives and will serve as a lead technical partner to stakeholders in the Dermatology Business Unit.

Sign up with Google

Sign in with Google